Harm van Tinteren
Harm van Tinteren
Hoofd afdeling Biometrics, Antoni van Leeuwenhoek
Verified email at
Cited by
Cited by
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis …
VJ Verwaal, S van Ruth, E de Bree, GW van Slooten, H van Tinteren, ...
Journal of clinical oncology 21 (20), 3737-3743, 2003
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of …
VJ Verwaal, S Bruin, H Boot, G Van Slooten, H Van Tinteren
Annals of surgical oncology 15 (9), 2426-2432, 2008
Hyperthermic intraperitoneal chemotherapy in ovarian cancer
WJ Van Driel, SN Koole, K Sikorska, JH Schagen van Leeuwen, ...
New England Journal of Medicine 378 (3), 230-240, 2018
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
H Van Tinteren, OS Hoekstra, EF Smit, JHAM Van Den Bergh, ...
The Lancet 359 (9315), 1388-1392, 2002
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium, AACR Project GENIE Consortium, ...
Cancer discovery 7 (8), 818-831, 2017
Risk of endometrial cancer after tamoxifen treatment of breast cancer
FE van Leeuwen, AW Van den Belt-Dusebout, J Benraadt, ...
The Lancet 343 (8895), 448-452, 1994
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
JB Vermorken, AME Claessen, H Van Tinteren, HE Gall, R Ezinga, ...
The Lancet 353 (9150), 345-350, 1999
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
BJ Slotman, H van Tinteren, JO Praag, JL Knegjens, SY El Sharouni, ...
The Lancet 385 (9962), 36-42, 2015
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
LHJ Simkens, H van Tinteren, A May, AJ ten Tije, GJM Creemers, ...
The Lancet 385 (9980), 1843-1852, 2015
EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer
N Van Zandwijk, O Dalesio, U Pastorino, N De Vries, H Van Tinteren
Journal of the National Cancer Institute 92 (12), 977-986, 2000
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
CU Blank, EA Rozeman, LF Fanchi, K Sikorska, B van de Wiel, ...
Nature medicine 24 (11), 1655-1661, 2018
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (6), 920-928, 2019
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
PCTC Group
The Lancet 355 (9214), 1491-1498, 2000
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18 F-fluorodeoxyglucose positron emission tomography
GJ Herder, H Van Tinteren, RP Golding, PJ Kostense, EF Comans, ...
Chest 128 (4), 2490-2496, 2005
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
A Cats, EPM Jansen, NCT van Grieken, K Sikorska, P Lind, M Nordsmark, ...
The lancet oncology 19 (5), 616-628, 2018
A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution's experience with consistent application of provox indwelling voice prostheses
BMRO de Coul, FJM Hilgers, AJM Balm, IB Tan, FJA Van den Hoogen, ...
Archives of Otolaryngology–Head & Neck Surgery 126 (11), 1320-1328, 2000
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
JM Bueno-de-Mesquita, WH van Harten, VP Retel, LJ van't Veer, ...
The lancet oncology 8 (12), 1079-1087, 2007
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
ME Straver, AM Glas, J Hannemann, J Wesseling, MJ van de Vijver, ...
Breast cancer research and treatment 119 (3), 551-558, 2010
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
S Kelderman, B Heemskerk, H Van Tinteren, RRH Van Den Brom, ...
Cancer Immunology, Immunotherapy 63 (5), 449-458, 2014
The system can't perform the operation now. Try again later.
Articles 1–20